Approved with the understanding that this pilot project is formative in nature and the results will not be able to be generalized. Given that this is not a randomized controlled design, effectiveness of the intervention cannot be robustly assessed through this ICR.
Inventory as of this Action
Requested
Previously Approved
05/31/2017
36 Months From Approved
10,060
0
0
5,113
0
0
0
0
0
CDC has partnered with Walgreen pharmacies to develop and implement a model of HIV care that integrates community pharmacists with primary medical providers for patient-centered HIV care. The model program will include the core elements of Medication Therapy Management as well as additional services such as individualized medication adherence counseling, active monitoring of prescription refills and active collaboration with medical clinic providers to identify and resolve medication related treatment problems such as treatment effectiveness, adverse events and poor adherence.
The pilot program will be conducted in ten project sites. Each project site will be made up of at least one Walgreens pharmacy and one medical clinic with which the pharmacy will partner. A total of 1000 HIV-infected persons (~100 patients per site) will be enrolled in the patient-centered HIV care project. The project sites will enroll minority populations disproportionately affected by HIV. Walgreens will provide expanded MTM services to participants of the pilot program and will work with medical clinic providers to implement the service model. Each project participant will receive patient-centered HIV care services for 18-24 months. The expected project outcomes are increased retention in care, adherence to HIV medication therapy and HIV viral load suppression.
US Code:
42 USC 301
Name of Law: Public Health Service Act
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
SupSta B.docx
Att 2 60 Day FRN.pdf
Pharmacy Record Abstraction Form